Novai study supports DARC imaging to identify risk of vision loss from macular atrophy

Novai, a medtech company focused on early detection of eye diseases, published a peer-reviewed study demonstrating that its DARC imaging technology can serve as a biomarker to identify patients at high risk of central vision loss due to macular atrophy. This development highlights a promising tool for early intervention in vision-threatening conditions.

Originally published by gnews